|
Our focus on early stage trials allows us unique insight into the most prevalent challenges at this phase of testing. We have strategically built an infrastructure, methodology and facility that meet those needs.
Our business model focuses on Phase I-III clinical trials, including:
- First-In-Human Studies
- Dose Escalation
- Bioavailability / Bioequivalence
- Pharmacokinetic / Pharmacodynamic (PK/PD)
- Drug-Drug Interaction
- Food Effect Studies
- Vaccine Development
- Novel Delivery Systems
- Radio Labeling / Mass Balance
- Challenge Studies
- Receptor Occupancy
- Proof of Concept
Our staff's experience in clinical trials encompasses a broad spectrum of therapeutic areas, including:
- CNS
- Women's Health
- Infectious Disease
- Immunology
- Cardiovascular
- Metabolic Disease
- Ophthalmology
- Urology
- Nephrology
SNBL CPC is a trusted partner prepared to support your research needs. We provide:
- Capacity Available Guarantee™
- Dedicated Phase I Project Management Team
- Rapid set-up program
- Flexible reporting formats and real-time tracking
- Expedited sample turnaround
- Flexible trial protocol and configuration
- Real Time Reporting and Advanced Data Management
- Quality Assurance
|
Print